Selected region : west
Date: : 28th Jun 2019

Current Studies:

The iPREVENT Study

Location: Glasgow (Glasgow Royal Infirmary)

Researchers at Glasgow Royal Infirmary (GRI) are looking for volunteers to take part in a study which is investigating the effects of a new food supplement on the prevention of weight gain in young adults who are at high risk of gaining weight.

At the first main study visit, you will be randomly allocated to receive either the inulin propionate ester supplement or inulin supplement, and you won’t know which. The supplements will be in sachets which can be taken with cold food or drink (sprinkled or mixed in) once a day. This study will run for 12 months and there will be a total of 5 visits to GRI.

If you would like to find out more about this study, please click here


The Towards Precision Medicine for Bipolar Disorder Study

Location: Glasgow (Queen Elizabeth Univeristy Hospital)

Although lithium therapy is regarded as the gold-standard treatment for bipolar disorder it can be associated with important long-term side-effects and there is currently no reliable method for accurately predicting which patients will respond well to lithium.

In the last few years several research studies have found that genetic factors may have an influence on the response to lithium in bipolar disorder. This study will be assessing whether genetic and non-genetic factors are potentially useful for predicting response to lithium.

For this study the researchers are looking for people with a diagnosis of bipolar disorder and are being treated with lithium or have received lithium treatment in the past.

If you would like to find out more about this study then please click here.


The GoDARTS Study: Genetics of Diabetes Audit and Research in Tayside and Scotland.

Location: Glasgow (Glasgow Royal Infirmary or Queen Elizabeth University Hospital) and Lanarkshire (Monklands, Hairmyres or Wishaw)

This study wants to understand the role our genes, and other biological markers, play in developing and managing diabetes. By conducting this research it will hopefully provide some answers to some of the following questions surrounding the disease; why do some people develop the disease and others don't; why does medication work for some groups of patients with diabetes and not for others and why do some people develop the complications associated with diabetes and others don't.

The other aim of this study is to look at Metformin, which is one of the most commonly used drugs to treat type 2 diabetes. It can also be used in the treatment of type 1 diabetes in conjunction with insulin therapy. Metformin has been on the market for over 60 years yet its mechanism of action is not fully understood. Some patients respond well to the treatment and encounter very little problems, whilst others find it does not work for them and causes many side-effects.

If you would like to find out more about this study then please click here.


The Inhaled SNG001 Study

Location: Glasgow (Gartnavel General Hospital)

For this study researchers are looking for volunteers who have COPD to take part in a study which is investigating a medication called SNG001. It contains Interferon-B which is a protein that occurs naturally in the body. One of its functions is to fight viruses. Interferon-B has been given to thousands of patients for other diseases e.g. multiple sclerosis.

Recent research has suggested that Interferon-B might protect the cells in the lungs from cold and flu viruses. The common cold virus is known to cause a worsening of COPD symptoms (exacerbation) in some individuals. It is hoped that one day SNG001 will be given as a treatment to people with COPD to prevent an exacerbation of symptoms caused by the common cold.

If you would like to find out more about this study then please click here.


The Scottish Epilepsy Study

Location: Glasgow and Lanarkshire

Research doctors are conducting a study in people with epilepsy. The reason they are doing this is because some people with epilepsy have accidents and complications of their condition. The research doctors want to see if by changing the way that services are delivered to people with epilepsy, or the way their condition is treated, it may be possible to help people with epilepsy and also raise national awareness of the importance of epilepsy in Scotland. Your experiences are extremely valuable to them.

This study is an observational study that does not involve any trips to the hospital or taking any treatments. 

If you would like to find out more about this study please call 01382 383431/383235 or email studies@registerforshare.org.